In HNSCC, it has been shown that tumor cells, through the secretion of FGF2, promote the activation of the FGF2/FGFR2 axis in cancer-associated fibroblasts (CAFs) in the dermis. This evidence concerns the gene FGF2 and head and neck squamous cell carcinoma.